Elliot Norry
Chief Tech/Sci/R&D Officer at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 168 269 $ as of 2024-03-30
Network origin in Elliot Norry first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 41 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Elliot Norry via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | General Counsel Chief Executive Officer | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Investor Relations Contact | |
| ABCAM PLC | Biotechnology | Director/Board Member Director of Finance/CFO | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ZYNERBA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact Human Resources Officer | |
| TESARO INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Director of Finance/CFO Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Morgan Stanley Venture Partners
 Morgan Stanley Venture Partners Investment ManagersFinance Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Pennsylvania State University | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of Durham | College/University | Undergraduate Degree Undergraduate Degree | |
| London Business School | College/University | Director/Board Member Masters Business Admin | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
PhosphonicS Ltd.
 PhosphonicS Ltd. BiotechnologyHealth Technology PhosphonicS Ltd. develops products for separation and purification of solid materials. Its products include screening kits, bulk materials and pre-engineered solutions. The firm serves Pharmaceuticals, Chemicals, Mining Refineries, Metal Recovery and Recycling, Electronics and Natural Extracts industries. The company was founded in 2003 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Chairman | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Chairman Director/Board Member Corporate Secretary Founder Chairman Director/Board Member Director/Board Member Founder Director/Board Member Director of Finance/CFO | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree Undergraduate Degree | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | President Director/Board Member Chief Executive Officer Director/Board Member | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
Adaptimmune LLC
 Adaptimmune LLC Medical/Nursing ServicesHealth Services Part of Adaptimmune Therapeutics Plc, Adaptimmune LLC is a private company that focuses on the use of T cell therapy to treat cancer and infectious disease. The company is based in Philadelphia, PA. | Medical/Nursing Services | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| NKARTA, INC. | Biotechnology | Chairman | |
Wardsend Ltd.
 Wardsend Ltd. Financial ConglomeratesFinance Wardsend Ltd. is an investment services provider founded in 1989. The private company is based in Oxford, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member | |
| OYSR POIN | Pharmaceuticals: Major | Chairman |
Statistics
International
| United States | 33 |
| United Kingdom | 15 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 6 |
| Health Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 247 |
| Independent Dir/Board Member | 94 |
| Corporate Officer/Principal | 87 |
| Chairman | 41 |
| Chief Tech/Sci/R&D Officer | 28 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| Peter Thompson | 39 |
| James Noble | 39 |
| Ali Behbahani | 34 |
| J. Kenneth Charles Knowles | 29 |
| Barbara Duncan | 22 |
| Charles Sigal | 20 |
| Garry Menzel | 19 |
| Ian Michael Laing | 19 |
| Andrew Allen | 18 |
| Kristen Hege | 17 |
| Giles Kerr | 16 |
| William Bertrand | 16 |
| Tal Zaks | 12 |
| Lawrence Alleva | 12 |
- Stock Market
- Insiders
- Elliot Norry
- Company connections
